Abstract
Polyphenolic compounds are reported to have various pharmacological activities such as anti-oxidative, anti-cancerous, anti-inflammatory and anti-aging effects. Although numerous papers explore their functional roles in many different cellular actions, not many studies handle their structural features in anti-inflammatory responses. In this study, therefore, we examined structural role of substituted transstilbenes in their NO inhibitory and NF-κB suppressive activities. Of 10 compounds tested, 4 compounds (cinnamic acid, resveratrol, piceatannol and curcumin) displayed NO inhibitory activities in a dose-dependent manner. Similarly, these compounds blocked LPS-induced cytotoxicity of RAW264.7 cells. All NO inhibitory compounds also inhibited IκBα phosphorylation, a hallmark for NF-κB activation. However, these inhibitory compounds exhibited distinct suppressive pattern in tumor necrosis factor (TNF)-α- or phorbol-12-myristate-13- acetate (PMA)-induced NF-κB and AP-1 activation. According to structure-activity relationship study, polarity and size of ring B seem to be important for diminishing NO production. Therefore, our data suggest that substituted trans-stilbenes can be developed as novel anti-inflammatory drug or further developed as lead compounds for another improvement.
| Original language | English |
|---|---|
| Pages (from-to) | 79-85 |
| Number of pages | 7 |
| Journal | Biomolecules and Therapeutics |
| Volume | 17 |
| Issue number | 1 |
| DOIs | |
| State | Published - Jan 2009 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- NF-κB
- NO production
- Polyphenolic compounds
- Structure-activity relationship study
- Substituted trans-stilbenes
Fingerprint
Dive into the research topics of 'Structural features of polyphenolic compounds in their NO inhibitory activities'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver